Phase 1 study of darolutamide (ODM-201): a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer
Titel:
Phase 1 study of darolutamide (ODM-201): a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer
Auteur:
Matsubara, Nobuaki Mukai, Hirofumi Hosono, Ako Onomura, Mai Sasaki, Masaoki Yajima, Yoko Hashizume, Kensei Yasuda, Masanobu Uemura, Miho Zurth, Christian